MIP: SGLT2 Inhibitors Versus Metformin: Dr Vigneshwaran Rajendran
M3 India Newsdesk Dec 08, 2023
MIP: SGLT2 Inhibitors Versus Metformin: Dr Vigneshwaran Rajendran
Watch Dr Vigneshwaran Rajendran explain th... more»Watch Dr Vigneshwaran Rajendran explain the cardiovascular effects of SGLT2 inhibitors, renal effects of SGLT2 inhibitors, how to compare OHA's based on cardiovascular benefits. He also mentions the latest guidelines along with a case study. «less
By Vigneshwaran Rajendran | Dec 08, 2023
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
